GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Gross-Profit-to-Asset %

Valeo Pharma (Valeo Pharma) Gross-Profit-to-Asset % : 22.38% (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Valeo Pharma's annualized Gross Profit for the quarter that ended in Jan. 2024 was $6.73 Mil. Valeo Pharma's average Total Assets over the quarter that ended in Jan. 2024 was $30.06 Mil. Therefore, Valeo Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2024 was 22.38%.


Valeo Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Valeo Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Gross-Profit-to-Asset % Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 30.32 16.46 25.24 15.43 26.27

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.91 36.90 36.76 5.72 22.38

Competitive Comparison of Valeo Pharma's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeo Pharma's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Gross-Profit-to-Asset % falls into.



Valeo Pharma Gross-Profit-to-Asset % Calculation

Valeo Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Oct. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Oct. 2023 )/( (Total Assets (A: Oct. 2022 )+Total Assets (A: Oct. 2023 ))/ count )
=9.537/( (42.563+30.052)/ 2 )
=9.537/36.3075
=26.27 %

Valeo Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Jan. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jan. 2024 )/( (Total Assets (Q: Oct. 2023 )+Total Assets (Q: Jan. 2024 ))/ count )
=6.728/( (30.052+30.063)/ 2 )
=6.728/30.0575
=22.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jan. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Valeo Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (Valeo Pharma) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.